Regulatory Digest 2026-03-07

Evidence Watch
✦ New

Regulatory updates (digest-only, lower relevance)

  1. (57) [regulations.gov] Importer of Controlled-Bright Green(2024-20083)DEA1426
  2. (57) [regulations.gov] Importer of Controlled-Cambridge Isotope(2024-20082)DEA1429
  3. (57) [regulations.gov] Importer Controlled-VA Cooperative (2024-11795) DEA1374
  4. (47) [regulations.gov] Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
  5. (43) [regulations.gov] Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I
  6. (42) [regulations.gov] Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
  7. (42) [regulations.gov] Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
  8. (42) [regulations.gov] Schedules of Controlled Substances: Temporary Placement of MDMB–4en–PINACA, 4F–MDMB–BUTICA, ADB–4en–PINACA, CUMYL–PEGACLONE, 5F–EDMB–PICA, and MMB–FUBICA into Schedule I
  9. (42) [regulations.gov] Schedules of Controlled Substances: Placement of Metonitazene in Schedule I
  10. (42) [regulations.gov] Schedules of Controlled Substances: Temporary Placement ofEtizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I
  11. (35) [regulations.gov] Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I
  12. (35) [regulations.gov] Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
  13. (35) [regulations.gov] Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I
  14. (35) [regulations.gov] Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
  15. (35) [regulations.gov] Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I
  16. (22) [regulations.gov] Medicare and Medicaid Programs; CY 2025 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Prescription Drug Inflation Rebate Program (CMS-1807-P)
  17. (15) [regulations.gov] Medicare and Medicaid Programs: Calendar Year 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; etc.
  18. (5) [regulations.gov] Medicare and Medicaid Programs; CY 2024 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Continued Implementation of Requirements for Manufacturers of Certain Single-dose Container or Single-use Package Drugs to Provide Refunds with Respect to Discarded Amounts; Medicare Advantage (CMS-1784-F)
  19. (5) [regulations.gov] Medicare and Medicaid Programs; CY 2024 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Continued Implementation of Requirements for Manufacturers of Certain Single-dose Container or Single-use Package Drugs to Provide Refunds with Respect to Discarded Amounts; Medicare Advantage (CMS-1784-P)
  20. (2) [regulations.gov] Definition of Engaged in the Business as a Dealer in Firearms